Takahiro Tsukimura

1.1k total citations
47 papers, 868 citations indexed

About

Takahiro Tsukimura is a scholar working on Physiology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Takahiro Tsukimura has authored 47 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Physiology, 22 papers in Organic Chemistry and 22 papers in Epidemiology. Recurrent topics in Takahiro Tsukimura's work include Lysosomal Storage Disorders Research (45 papers), Trypanosoma species research and implications (22 papers) and Carbohydrate Chemistry and Synthesis (22 papers). Takahiro Tsukimura is often cited by papers focused on Lysosomal Storage Disorders Research (45 papers), Trypanosoma species research and implications (22 papers) and Carbohydrate Chemistry and Synthesis (22 papers). Takahiro Tsukimura collaborates with scholars based in Japan, United States and Germany. Takahiro Tsukimura's co-authors include Hitoshi Sakuraba, Tadayasu Togawa, Takashi Kodama, Toshihiro Suzuki, Kazuki Ohno, Ikuo Kawashima, Kanako Sugawara, Hiroshi Kato, Seiji Saito and Youichi Tajima and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Takahiro Tsukimura

46 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takahiro Tsukimura Japan 18 769 380 310 243 222 47 868
Robert Dobrovolný Czechia 13 640 0.8× 302 0.8× 190 0.6× 154 0.6× 208 0.9× 17 753
Tina Rozaklis Australia 17 659 0.9× 231 0.6× 145 0.5× 236 1.0× 253 1.1× 24 835
Cordula Steglich Germany 16 609 0.8× 358 0.9× 158 0.5× 226 0.9× 132 0.6× 24 805
E. Young United Kingdom 15 664 0.9× 281 0.7× 138 0.4× 175 0.7× 179 0.8× 23 768
Ya. V. Voznyi Russia 12 592 0.8× 248 0.7× 140 0.5× 206 0.8× 171 0.8× 19 685
Leanne K. Hein Australia 17 522 0.7× 288 0.8× 129 0.4× 232 1.0× 193 0.9× 34 734
Hadhami Ben Turkia Tunisia 13 417 0.5× 151 0.4× 151 0.5× 171 0.7× 153 0.7× 46 524
Helen Christomanou Germany 9 608 0.8× 236 0.6× 162 0.5× 340 1.4× 266 1.2× 9 717
Masahisa Kobayashi Japan 15 427 0.6× 212 0.6× 122 0.4× 113 0.5× 131 0.6× 38 564
Marie T. Vanier France 8 496 0.6× 94 0.2× 193 0.6× 183 0.8× 120 0.5× 9 611

Countries citing papers authored by Takahiro Tsukimura

Since Specialization
Citations

This map shows the geographic impact of Takahiro Tsukimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Tsukimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Tsukimura more than expected).

Fields of papers citing papers by Takahiro Tsukimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Tsukimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Tsukimura. The network helps show where Takahiro Tsukimura may publish in the future.

Co-authorship network of co-authors of Takahiro Tsukimura

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Tsukimura. A scholar is included among the top collaborators of Takahiro Tsukimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Tsukimura. Takahiro Tsukimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsukimura, Takahiro, et al.. (2024). Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?. Molecular Genetics and Metabolism Reports. 39. 101079–101079. 1 indexed citations
2.
Chen, Yen‐Hsi, Weihua Tian, Makiko Yasuda, et al.. (2023). A universal GlycoDesign for lysosomal replacement enzymes to improve circulation time and biodistribution. Frontiers in Bioengineering and Biotechnology. 11. 1128371–1128371. 4 indexed citations
3.
4.
Tsukimura, Takahiro, et al.. (2021). Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?. Molecular Genetics and Metabolism Reports. 28. 100773–100773. 5 indexed citations
5.
Tsukimura, Takahiro, et al.. (2020). Surface plasmon resonance analysis of complex formation of therapeutic recombinant lysosomal enzymes with domain 9 of human cation-independent mannose 6-phosphate receptor. Molecular Genetics and Metabolism Reports. 25. 100639–100639. 6 indexed citations
6.
Nakayama, Yosuke, Shoichiro Nakao, Ryo Yamamoto, et al.. (2019). Effectiveness of immunosuppressive therapy for nephrotic syndrome in a patient with late-onset Fabry disease: a case report and literature review. BMC Nephrology. 20(1). 469–469. 10 indexed citations
7.
Sakuraba, Hitoshi, Takahiro Tsukimura, Tadayasu Togawa, et al.. (2018). Fabry disease in a Japanese population-molecular and biochemical characteristics. Molecular Genetics and Metabolism Reports. 17. 73–79. 27 indexed citations
8.
Ogawa, Yasuhiro, Takashi Kodama, Takahiro Saito, et al.. (2017). FcRγ-dependent immune activation initiates astrogliosis during the asymptomatic phase of Sandhoff disease model mice. Scientific Reports. 7(1). 40518–40518. 20 indexed citations
9.
Kubo, Toru, Yuichi Baba, Takayoshi Hirota, et al.. (2016). Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy. Journal of Cardiology. 69(1). 302–307. 27 indexed citations
10.
Kodama, Takashi, Takahiro Tsukimura, Ikuo Kawashima, et al.. (2016). Differences in cleavage of globotriaosylceramide and its derivatives accumulated in organs of young Fabry mice following enzyme replacement therapy. Molecular Genetics and Metabolism. 120(1-2). 116–120. 9 indexed citations
11.
Tsukimura, Takahiro, Tadayasu Togawa, Toya Ohashi, et al.. (2015). Rapid Immunochromatographic Detection of Serum Anti-α-Galactosidase A Antibodies in Fabry Patients after Enzyme Replacement Therapy. PLoS ONE. 10(6). e0128351–e0128351. 12 indexed citations
12.
13.
Tsukimura, Takahiro, Tadayasu Togawa, Seiji Saito, et al.. (2014). Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease. Molecular Genetics and Metabolism Reports. 1. 288–298. 10 indexed citations
14.
Morizane, Y., Toshihiro Suzuki, Tadayasu Togawa, et al.. (2013). Development of a Highly Sensitive Immuno-PCR Assay for the Measurement of α-Galactosidase A Protein Levels in Serum and Plasma. PLoS ONE. 8(11). e78588–e78588. 10 indexed citations
15.
Nishida, Masashi, Koh Hasegawa, Toshiyuki Itoi, et al.. (2013). A case of Fabry nephropathy with histological features of oligonephropathy. European Journal of Pediatrics. 173(8). 1111–1114. 6 indexed citations
16.
Togawa, Tadayasu, Takahiro Tsukimura, Takashi Kodama, et al.. (2012). Fabry disease: Biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution. Molecular Genetics and Metabolism. 105(4). 615–620. 33 indexed citations
17.
Tsukimura, Takahiro, Ikuo Kawashima, Tadayasu Togawa, et al.. (2011). Efficient Uptake of Recombinant α-Galactosidase A Produced with a Gene-Manipulated Yeast by Fabry Mice Kidneys. Molecular Medicine. 18(1). 76–82. 14 indexed citations
18.
Togawa, Tadayasu, Ikuo Kawashima, Takashi Kodama, et al.. (2010). Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease. Biochemical and Biophysical Research Communications. 399(4). 716–720. 31 indexed citations
19.
Tajima, Youichi, Ikuo Kawashima, Takahiro Tsukimura, et al.. (2009). Use of a Modified α-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease. The American Journal of Human Genetics. 85(5). 569–580. 41 indexed citations
20.
Tajima, Youichi, Fumiko Matsuzawa, Toshika Okumiya, et al.. (2007). Structural and biochemical studies on Pompe disease and a “pseudodeficiency of acid α-glucosidase”. Journal of Human Genetics. 52(11). 898–906. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Dobrovolný Breakdown of academic impact, for papers by Tina Rozaklis Breakdown of academic impact, for papers by Cordula Steglich Breakdown of academic impact, for papers by E. Young Breakdown of academic impact, for papers by Ya. V. Voznyi Breakdown of academic impact, for papers by Leanne K. Hein Breakdown of academic impact, for papers by Hadhami Ben Turkia Breakdown of academic impact, for papers by Helen Christomanou Breakdown of academic impact, for papers by Masahisa Kobayashi Breakdown of academic impact, for papers by Marie T. Vanier
Rankless by CCL
2026